|
HS Code |
130131 |
| Product Name | 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin |
| Molecular Formula | C20H16O4 |
| Molecular Weight | 320.34 g/mol |
| Appearance | White to off-white powder |
| Melting Point | 156-159°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Cas Number | 6035-62-1 |
| Structure Type | Coumarin derivative |
| Purity | Typically >98% |
| Storage Temperature | Store at 2-8°C |
| Pka | Approximately 7.1 (hydroxyl group) |
| Density | Approx. 1.35 g/cm³ |
| Iupac Name | 3-(1-(4-hydroxy-2-oxo-2H-chromen-3-yl)ethyl)-1-phenylpropan-1-one |
As an accredited 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin, tightly sealed, with hazard and identification labeling. |
| Shipping | The chemical 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin is shipped in tightly sealed, inert containers under controlled temperature conditions to prevent degradation. Proper labeling, cushioning, and adherence to regulatory guidelines for hazardous materials ensure safe transport. Transport complies with international safety standards, including documentation and safety data sheets, for secure delivery. |
| Storage | Store 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin in a tightly sealed container, protected from light and moisture. Keep in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizers or acids. Avoid exposure to excessive heat. Label the container clearly and follow all relevant safety protocols for storage of organic and potentially hazardous chemicals. |
Applications of 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin in Industrial ManufacturingAs the direct producer, we supply 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin to specialized industrial sectors with mature downstream processes. This compound delivers proven performance in select applications where high purity and controlled properties are essential for both process reliability and regulatory compliance. Below, we detail its established use-cases, specifying operational guidelines and industry benchmarks for each segment. 1. Anticoagulant Pharmaceutics (Active Pharmaceutical Ingredient Synthesis)This coumarin derivative features as a core intermediate in anticoagulant pharmaceutical manufacture, serving as a key molecule in the synthesis of vitamin K antagonist drugs for the treatment and prevention of thromboembolic disorders. Manufacturers employ it in stepwise reactions requiring precise molar control and rigorous in-process analytical verification for compliance with pharmacopeial monographs. Carefully monitored integration supports the production of finished oral solid and parenteral dosage forms with predictable pharmacodynamic profiles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Rodenticide Technical Active Ingredient ManufacturingIn the field of professional pest management, formulators employ this coumarin-based molecule in the production of second-generation anticoagulant rodenticides. The strict quality requirements of this application demand high assay material and consistent impurity profiles to ensure lethal efficacy at low ppm concentrations, as well as reliable environmental fate in accordance with regulatory risk assessments. Batching and dissolution occur in contained systems to safeguard both process operatives and end-user safety, incorporating precise gravimetric dosing and solvent compatibility screening. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Fluorescent Marker Manufacture for Analytical ReagentsDedicated manufacturers of diagnostic and analytical kits utilize this high-purity aromatic molecule in the production of specialty fluorescent probes. Its core structure offers unique fluorescence emission suitable for sensitive detection assays, particularly where reliable signal intensity and low basal noise are critical. The downstream production focuses on precise derivatization and conjugation steps, followed by tight particle size and purity control to meet demanding laboratory and field analysis protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Industrial Fine Chemical Synthesis – Dye IntermediatesIn the specialty dye sector, this coumarin-based compound operates as a critical building block for the synthesis of high-performance fluorescent and laser dyes. Downstream integration focuses on multi-step organic transformation involving controlled ring substitution and coupling reactions. Manufacturers rely on this material for applications requiring photo-stable and tunable chromophores, where even minor contaminant variation can affect the optical and chemical stability of the finished product. Comprehensive screening for feedstock compatibility is always performed prior to scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the ever-changing world of fine chemical manufacturing, specialty intermediates play a crucial role in research and production. 3-(Α-Acetylmethylbenzyl)-4-Hydroxycoumarin reflects the drive toward higher selectivity and more tailored molecular frameworks found in experimental synthesis today. Because we handle every stage from raw material selection through to the last point of packaging, the details behind this substance’s synthesis and reliability matter to us in very practical ways.
We started producing 3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin after receiving regular feedback from labs and formulation scientists searching for better options than legacy 4-hydroxycoumarins and related benzylated derivatives. Those materials often fell short when customers demanded a combination of specific reactivity, clean aromatic substitution profiles, and batch reliability. This molecule arose directly from requests for tighter process control and stronger batch-to-batch traceability, rather than being picked from a catalog.
What sets this compound apart becomes clear as we weigh the practical results that stem from changing the acetylmethylbenzyl substituent at position 3 of the 4-hydroxycoumarin skeleton. Experienced chemists notice its pronounced impact on downstream reactivity. The unique arrangement influences stereo-electronic effects—both the electron-rich hydroxy and aromatic ring, and the acetylmethylbenzyl group, play into coupling or substitution chemistry, often reducing side reactions that are a headache during complex syntheses. Aberrant impurities and unintended byproducts drop noticeably.
By producing this compound at scale, we get a close-up look at how it works—far more so than if we were merely passing along contract-made material. Our synthesis routes rely on original, optimized steps that cut down on unwanted tars and color bodies, delivering a product that responds well to analytical checks such as HPLC or NMR. Chemists have pointed out the significance of this: fewer clean-up steps, less column time, and rarely any surprise chromatographic peaks.
Our manufacturing background lets us see the bigger picture in downstream applications. 3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin lands in a zone that often affects pharmaceuticals, specialty crop protection agents, optical brighteners, and even advanced organic materials. The hydroxycoumarin family remains a critical platform. Many compounds used in anticoagulants, signal markers, and plastics rely on clean, repeatable intermediates at this stage of synthesis.
Out in the real world, minor variations in raw feedstock, temperature control, or storage can lead to batch failures. We catch that sort of problem before shipping. Manufacturing in-house, we’ve learned to vet every precursor, confirm solvents by GC-MS, and hold finished material for trending and purity analysis. Several global clients producing active pharmaceutical ingredients appreciate not just purity by HPLC but also evidence that trace residuals sit within accepted specifications every time. Product recalls trace back to vendors who didn’t invest in this kind of rooted manufacturing control.
Working with 3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin gives synthetic chemists an edge compared to more generic hydroxycoumarins and their derivatives. The substituted benzyl side group alters lipophilicity and improves solubility in a variety of organic solvents, especially those encountered in upstream multi-step reactions and medicinal chemistry. Direct substitution at the 3-position, as we saw in our own scale-up runs, brings advantages over downstream functionalization of unsubstituted 4-hydroxycoumarin: yields in subsequent steps jump, crude product handling is simplified, and the isolation of pure end-product becomes more straightforward.
While simple 4-hydroxycoumarins or generic 3-benzyl substituents offer some versatility, unwanted regioisomers or double-acylated impurities add headaches in process development. We receive direct feedback from process chemists tackling scale-up for patent filings. They prefer intermediates like this—already pre-modified—because custom substitution helps avoid unwanted reactions with acylating or alkylating agents at later stages.
With hands-on insights, our team discovered that downstream syntheses using this intermediate cut down on the demand for repeated recrystallization. The final product appears as an off-white to faint yellow solid, with melting ranges confirmed batch by batch. We run infrared and NMR checks to pick up even minor deviation in molecular structure, as customers doing late-stage pharmaceutical scale-up scrutinize every detail before regulatory submission. Solubility characteristics in mixed polar-aprotic systems expand the compound’s value in exploratory synthesis, facilitating high-yield and low-waste transformations.
From years of refining the process, we have fixed the standard batch specification at a purity over 98% by HPLC (area normalization). Our lots consistently perform within a narrow melting point bracket, which reflects good control of side reactions and solvent residues. Each stage, from condensation of the coumarin core to final acetylation and benzylation, takes place in dedicated, monitored reactors. No contract manufacturing shortcuts mean every sack of raw material and every drum of solvent undergo direct oversight—years of shop floor experience tell us that shortcuts cost dearly in fines, setbacks, and credibility.
We package this product in lined drums and nitrogen-purged containers, depending on customer shipping mode. Over time, storage and stability testing confirmed no unusual color deepening or loss of activity under standard warehouse conditions. Our shipping records show that temperature fluctuations during transport don’t affect purity for transport periods under thirty days. If unusual storage conditions are required in a customer’s facility, we furnish detailed compatibility information based on our own data, not generic supplier leaflets.
3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin fills a real need in both benchtop and manufacturing scale operations. When new requests come in from R&D teams—especially those working on antifungal actives or advanced ligand frameworks—we review their route and share experiences from our own plant trials. Many have updated their internal protocols to take advantage of this intermediate’s enhanced compatibility with solvent blends, higher solubility in commonly used acetates or ethers, and predictable crystallization profile.
One of our longtime partners in custom science reagent production mentioned a noticeable drop in batch rejection rates when switching to our product, made in-house. Instead of adjusting purification methods to match lots from different suppliers, they settle into reliable, repeatable routines. We have gathered plenty of similar stories from scale-up labs serving pilot plant runs of new pharmaceutical candidates or engineered agricultural agents.
The technical service team receives routine feedback on both handling convenience and analytical clarity—end users see sharp, predictable signals in their spectra, with no mystery signals from side-products typical of loosely controlled manufacturing. On more than one occasion, we troubleshoot side reactions that puzzled researchers using impure or inconsistent competitors’ material. Drawing from experience on the manufacturing line, we offer solutions based on solvent tweaks or purification adjustments that our batch data back up.
We know plant safety is not a paperwork exercise. From the start, we set out to keep every step of production compliant and auditable, minimizing environmental impact while safeguarding our workers. Solvent choices and waste handling stem from practical lessons. Leaner, contained benzylation steps keep emissions lower and reduce the risk of off-gassing or hazardous decomposition—no one on the shop floor misses the old ways of working with vented vats in minimal containment.
Purification processes capture and recycle solvents as far as technical feasibility allows, and solid waste streams end up directed to authorized handlers without fuss. Inspection logs go beyond regulatory minimums, as our own standards for workplace health demand all personnel can trace back any anomaly to a process point. Chemical spills or cross-contaminations are already rare, but in daily practice, we run tight controls on batch start and finish—those steps matter for quality along with environmental compliance.
Many buyers underestimate how much real control over raw material intake and process steps shapes the finished product. Onlookers might see surface-level differences—at best, a passing certificate of analysis. Our bulk buyers know the real value comes from engineering repeatable processes beginning with sealed containers from verified suppliers. No open-air handling, no odd solvents whose effect on process safety is questionable, and nothing left to chance during purification.
Lot-to-lot consistency is more than a selling point. Customers drawing a single batch for clinical candidate scale-up or registration runs must avoid any sudden changes or performance deviations; otherwise, regulatory milestones or project budgets get hit. Anyone who ever lost a month to non-conforming material from a careless source never wants to repeat that risk.
Clients need records of the same lot being sampled and tracked in real time, not just initial qualification. We don’t treat process deviation as routine—every outlier triggers a full process review and test rerun, often run by the same technicians who handled that specific batch. This traceability builds trust over years of partnership, not just one-off supply contracts.
Generic intermediates may look similar on a typical chemical structure printout, but that does not translate into the experience at scale. Generic 4-hydroxycoumarins sourced via trading chains show wider variance in melting points, color, and residue analysis. Stock produced without control over precursor purity takes more time and resources to clean up, especially as finer tolerances are demanded.
In our shop, in-line monitoring and intermediate isolation happen with the same care at every batch size. This attention comes from long experience with missed outputs when incoming raw acetylmethylbenzyl or solvent carries trace instability. Process engineers keep rigorous logs, flagging even minor NMR variances or color drifts. Unlike traders who work from warehouse inventories of unknown provenance, we run end-to-end operations, bringing valuable insights from decades of feedback, downtime logs, and batch reports.
Our lot-to-lot analytical tracers go further than standard purity checks. We run impurities profiling against proprietary in-house standards. Several partners involved in regulated industries only buy from direct producers who keep strict oversight and share batch-level supporting analysis.
Working as a manufacturer means more than just supplying a formula. Our support teams interact with synthetic chemists, process engineers, and QA/QC analysts looking for answers to real-world process and product improvement challenges. Years spent on the production floor, in the lab, and in quality review meetings lead to better dialogue and practical advice—advice grounded in handling every shipping and analytical issue that could arise from molecules like 3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin.
We still listen to front-line users—those carefully tracking product consistency, handling, and downstream performance. We fine-tune our processes around their input instead of pushing a one-size-fits-all standard. This happens through transparent feedback loops, not isolated sales pitches.
We learned long ago that high analytical standards are pivotal during scale-up, regulatory submission, and final product release. Production shifts are supported by fully staffed QC labs equipped to run both standard and more advanced chromatographic methods (HPLC, NMR, MS). Every certificate issued includes actual test data, not just minimum compliance statements. On many occasions, investigators have found tiny traces of side products that could slip through less rigorous supplier checks—but never from our batches.
Our experience shows ongoing, detailed records and spot-checks for every manufactured batch pay off in customer confidence. End-users especially appreciate being able to request sample retention vials from past lots. They can reproduce their own validation analysis or investigate product performance independently.
Sophisticated end-users choose direct manufacturers for the reliability and traceability that cannot be provided by intermediaries or resellers. Time after time, chemists, analysts, and formulation engineers mention fewer processing failures and accelerated project timelines due to the reliability of our batches. They do not need to change procedures each time a new delivery arrives.
From our vantage point, the value comes from the close cycles of manufacturing, analysis, and customer collaboration. That synergy reduces uncertainty, keeps project managers confident, and preserves hard-won research budgets. In the crowded specialty chemicals arena, trust and precision matter above all else.
Every container of 3-(Α-Acetylmethylbenzyl)-4-hydroxycoumarin we ship stands for years of industry experience, technical know-how, and face-to-face partnership with end-users. Years of plant operation reveal the consequences of ignoring small details—an unexpected batch failure, a missed deadline, or loss of a valued business relationship. Real manufacturing means investing in careful control, open feedback, and supporting the demands of innovation and safety.
We will continue to drive improvements, listen to our stakeholders, and keep every step transparent. Our company remains prepared to put our technical expertise and manufacturing discipline on the line, for every customer, every batch.